626 filings
ARS
2023 FY
PVCT
Provectus Biopharmaceuticals, Inc.
9 May 24
Annual report to shareholders
10:54am
DEFA14A
PVCT
Provectus Biopharmaceuticals, Inc.
6 May 24
Additional proxy soliciting materials
1:57pm
DEF 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Definitive proxy
6 May 24
1:56pm
PRE 14A
PVCT
Provectus Biopharmaceuticals, Inc.
Preliminary proxy
26 Apr 24
11:48am
8-K
ta8rq6kti3v 344nv
16 Apr 24
Provectus Biopharmaceuticals Announces Management Additions and Reiterates Commitment to Shareholder Value Creation
4:58pm
8-K
pas3fu 9eh7
27 Mar 24
Entry into a Material Definitive Agreement
12:10pm
8-K
qs0a2zqhxjxeeuc
26 Mar 24
Departure of Directors or Certain Officers
4:48pm
8-K
yrtb3lic6j88
22 Feb 24
Regulation FD Disclosure
9:30am
8-K
ni3yu2v tviigxw7zl
15 Feb 24
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
8:05am
8-K
z70u7rtufoz
22 Jun 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vlvx19kvznqjcu4
21 Jun 23
Regulation FD Disclosure
9:50am
DEFA14A
yjy s0cw6qpcn6r
21 Jun 23
Additional proxy soliciting materials
9:45am
ARS
ntwnfyssf29rbbm3en
11 May 23
Annual report to shareholders
3:18pm
DEFA14A
0wmekgxtdbagpu
1 May 23
Additional proxy soliciting materials
2:01pm